Q4 results hit Verano Holdings (VRNO.NE NEO) on 26 Feb 2026: margin outlook is the key
VRNO.NE stock trades at C$1.56 after Verano Holdings reported Q4 results on 26 Feb 2026. The market reacted during NEO market hours with shares down -2.50% on the session as investors parsed negative EPS and margin commentary. Verano reported trailing EPS -1.36 and keeps a negative operating margin. We focus on what the numbers mean for near-term revenue conversion, valuation versus peers, and the trading range investors should watch today.
VRNO.NE stock: earnings snapshot and market reaction
Verano Holdings (VRNO.NE) released earnings with an announcement time of 26 Feb 2026 08:30 EST. The stock opened at C$1.62, traded between C$1.55 and C$1.65, and closed near C$1.56 on the session. Volume rose to 3,026,861 versus an average volume of 313,277, showing heightened interest.
Earnings detail matters. Reported EPS is -1.36, and the company signaled mixed operational trends. Investors reacted to margin commentary, which pressured the stock during regular market hours on NEO in Canada.
VRNO.NE stock financials and key metrics
Verano’s trailing metrics show revenue per share C$2.30 and net income per share -C$0.96, with a price-to-sales ratio of 0.51. The PB ratio sits at 0.48, and free cash flow yield is 8.52%, indicating cash generation relative to market cap.
Balance sheet strengths include a current ratio of 2.69 and book value per share C$2.84. Weaknesses include negative operating margin -30.42% and interest coverage -4.73, which highlight profitability and leverage issues investors must weigh in the VRNO.NE analysis.
Meyka AI rates VRNO.NE with a score out of 100 and technical view
Meyka AI rates VRNO.NE with a score of 67.77/100, Grade B, suggestion HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. The grade does not guarantee returns and is informational only.
Technicals are mixed. RSI is 49.52, 50-day moving average is C$1.74, and 200-day moving average is C$1.46. Bollinger bands show a middle band at C$1.61, suggesting price consolidation. Recent momentum is muted, and the ADX at 15.02 signals no strong trend.
VRNO.NE stock valuation, sector context and risks
On valuation, VRNO.NE trades below book value and below many peers on PB, but margins remain negative. Price-to-sales 0.51 compares favorably to company-level expectations, yet the company’s return on equity is -37.47%, signaling weak profitability.
Sector context matters. Verano sits in Healthcare, Drug Manufacturers – Specialty & Generic. The sector average ROA is negative and liquidity norms vary. Key risks include regulatory shifts, continued negative margins, and interest coverage pressure. Opportunities include multi-state US retail scale and brand portfolio growth that could improve margins over time.
Short-term outlook, price targets and trading cues for VRNO.NE stock
Analyst signals are mixed and no broad price-target consensus is published. Company-level rating data shows a recent company rating of C+ with a sell recommendation on 24 Feb 2026. Use tight risk controls in the near term.
Practical price targets for trading: conservative C$1.20, base C$1.80, and bull C$3.00. Watch daily volume, consolidation above C$1.65 for upside confirmation, and breakdown below C$1.55 for downside risk. For recent market background and historical price data see Investing and recent company notices at MarketBeat.
Final Thoughts
Key takeaways: VRNO.NE stock trades at C$1.56 after Q4 results and faces a short-term battle between cash generation and negative margins. Balance sheet metrics show liquidity with a current ratio 2.69, but profitability remains the core issue. Meyka AI’s forecast model projects a short-term quarterly target of C$2.53, implying a +62.18% upside versus today, and a one-year projection of C$0.60, implying a -61.73% downside. These divergent model outputs reflect high scenario risk and earnings sensitivity.
Investors should treat forecasts as model-based projections and not guarantees. Monitor margin commentary, same-store sales trends, and interest coverage on upcoming disclosures. For a live data snapshot and additional signals visit the Meyka VRNO.NE page for AI-powered market analysis: Meyka VRNO.NE page.
FAQs
What drove VRNO.NE stock movement after the Q4 report?
The move reflected negative EPS -1.36, margin commentary and higher session volume 3,026,861. Investors focused on profitability and guidance, which pressured VRNO.NE stock during NEO market hours.
How does Verano’s valuation compare with sector peers for VRNO.NE stock?
VRNO.NE trades at PB 0.48 and PS 0.51, below many healthcare peers. The lower valuation reflects negative margins and profitability challenges relative to sector averages.
What is Meyka AI’s view on VRNO.NE stock right now?
Meyka AI rates VRNO.NE 67.77/100, Grade B and suggests HOLD. The grade factors in benchmark and sector comparisons, financial growth, key metrics and forecasts.
What short-term price levels should traders watch for VRNO.NE stock?
Key intraday levels: resistance near C$1.65, support near C$1.55. Trade confirmation requires a daily close above C$1.65 or a breakdown below C$1.55 with volume.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.